Author/Authors :
Diana A. Gorog، نويسنده , , Rodney A. Foale، نويسنده , , Iqbal Malik، نويسنده ,
Abstract :
The discrepancy between angiographic success and microvascular perfusion has been recognized for some time. In the face of an open artery, the degree of microvascular perfusion determines post-infarct prognosis. Despite successful epicardial recanalization, tissue perfusion may be absent in up to 25% patients with acute myocardial infarction. Historically associated with saphenous vein graft intervention, embolization is increasingly recognized in native coronary arteries, particularly in patients undergoing primary percutaneous coronary intervention (PCI). With more than two million PCI procedures performed worldwide each year, there is enormous interest in protecting the left ventricular myocardium from embolization during PCI. This article reviews the evidence for distal myocardial protection and discusses the relative merits of the different available techniques.
Keywords :
AMI , PCI , Acute coronary syndromes , Acute myocardial infarction , Glycoprotein , mace , Safe , Percutaneous coronary intervention , DPD , GP , SVG , Pride , saphenous vein graft , MBG , myocardial blush grade , ACS , CAS , carotid artery stenting , major adverse cardiac event , SAFER , Saphenous Vein Graft Angioplasty Free of Emboli Randomized trial , CAPTIVE , CardioShield Application Protects During Transluminal Intervention of Vein Grafts by Reducing Emboli , distal protection device , MMP9 , matrix metalloproteinase 9 , PRotection During Saphenous Vein Graft Intervention to Prevent Distal Embolization , Saphenous Vein Graft Angioplasty Free of Emboli trial